GW Pharmaceuticals Plc Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. GW Pharmaceuticals Plc latest Real Value cannot be determined due to lack of data. The recent price of GW Pharmaceuticals Plc is $0.0. Our model calculates the value of GW Pharmaceuticals Plc from inspecting the firm fundamentals such as Shares Owned By Insiders of 0.20 %, operating margin of (9.82) %, and Return On Asset of -3.55 as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors encourage purchasing undervalued equities and trading away overvalued equities since, sooner or later, asset prices and their ongoing real values will blend.
GW Pharmaceuticals Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining GW Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare GW Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GW Pharmaceuticals competition to find correlations between indicators driving GW Pharmaceuticals's intrinsic value. More Info.GW Pharmaceuticals Plc is one of the top stocks in beta category among related companies. It is one of the top stocks in price to book category among related companies fabricating about 5.53 of Price To Book per Beta. . Comparative valuation analysis is a catch-all model that can be used if you cannot value GW Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for GW Pharmaceuticals' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GW Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates GW Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in GW Pharmaceuticals and how it compares across the competition.
GW Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as GW Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Shares Percent Shares Out | 2.20% | |
Revenue Growth | 35.90% | |
Forward Price Earnings | 44.50 | |
Float Shares | 30.35M | |
Shares Short Prior Month | 393.65k |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in GWPH Stock
If you are still planning to invest in GW Pharmaceuticals Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GW Pharmaceuticals' history and understand the potential risks before investing.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |